4//SEC Filing
Aviragen Therapeutics, Inc. 4
Accession 0001140361-16-073916
$VXRTCIK 0000072444operating
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:54 PM ET
Size
5.6 KB
Accession
0001140361-16-073916
Insider Transaction Report
Form 4
COLONNESE MARK P
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-07-27$1.34/sh+150,000$201,000→ 375,000 totalExercise: $1.34From: 2017-07-27Exp: 2026-07-27→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal annual installments beginning on the first anniversary and thereafter on the second and third anniversary ratably.
Documents
Issuer
Aviragen Therapeutics, Inc.
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 4:54 PM ET
- Size
- 5.6 KB